Industry
Sera Prognostics, Inc.
Total Trials
4
Recruiting
0
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
Failure Rate
25.0%
1 terminated/withdrawn out of 4 trials
Success Rate
66.7%
-19.8% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
N/A
2(100.0%)
2Total
N/A(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT04301518Not ApplicableActive Not Recruiting
Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs
Role: lead
NCT02787213Completed
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor
Role: lead
NCT03530332Not ApplicableTerminated
Prediction and Prevention of Preterm Birth (PREVENT-PTB Study)
Role: collaborator
NCT01371019Completed
Proteomic Assessment of Preterm Birth
Role: lead
All 4 trials loaded